Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
39.48 USD | +0.10% | +9.94% | +33.74% |
08/07 | Mirum Pharmaceuticals Gets Marketing Approval for Livmarli in Europe | MT |
08/07 | Mirum Pharmaceuticals, Inc.' LIVMARLI Approves in the European Union for Patients with PFIC | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+33.74% | 186.08Cr | |
+22.15% | 4.66TCr | |
+45.04% | 4.17TCr | |
-2.37% | 4.12TCr | |
+33.84% | 3.24TCr | |
-6.35% | 2.81TCr | |
+20.42% | 2.82TCr | |
+48.83% | 1.45TCr | |
+45.00% | 1.37TCr | |
+0.06% | 1.22TCr |
- Stock Market
- Equities
- MIRM Stock
- News Mirum Pharmaceuticals, Inc.
- Mirum Pharmaceuticals Gets Marketing Approval for Livmarli in Europe